Vyne Therapeutics Inc (VYNE) — Cash Flow Quality Index

Latest as of March 2022: -1.94x

Vyne Therapeutics Inc (VYNE) has a Cash Flow Quality Index of -1.94x as of March 2022. Operating cash flow of $-9.04 Million is below net income of $4.67 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore VYNE cash flow conversion to assess how effectively this company generates cash.

Cash Flow Quality Index

-1.94x

Operating CF / Net Income

Operating Cash Flow

$-9.04 Million

USD

Net Income

$4.67 Million

USD

Data as of

Mar 2022

Most recent filing

Annual Cash Flow Quality Index for Vyne Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Vyne Therapeutics Inc. For live market cap and the full company financial profile, see market cap of Vyne Therapeutics Inc.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.